9.895
price up icon2.09%   0.235
 
loading
Precedente Chiudi:
$9.66
Aprire:
$9.92
Volume 24 ore:
403.42K
Relative Volume:
0.47
Capitalizzazione di mercato:
$2.59B
Reddito:
$7.94B
Utile/perdita netta:
$225.54M
Rapporto P/E:
29.99
EPS:
0.3299
Flusso di cassa netto:
$709.16M
1 W Prestazione:
-2.26%
1M Prestazione:
+17.82%
6M Prestazione:
+32.02%
1 anno Prestazione:
+27.25%
Intervallo 1D:
Value
$9.76
$9.97
Intervallo di 1 settimana:
Value
$9.66
$10.30
Portata 52W:
Value
$6.19
$10.30

Grifols Sa Adr Stock (GRFS) Company Profile

Name
Nome
Grifols Sa Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
23,822
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
GRFS's Discussions on Twitter

Confronta GRFS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - General icon
GRFS
Grifols Sa Adr
9.895 6.65B 7.94B 225.54M 709.16M 0.3299
Drug Manufacturers - General icon
LLY
Lilly Eli Co
787.11 692.83B 49.00B 11.11B -1.27B 12.29
Drug Manufacturers - General icon
JNJ
Johnson Johnson
167.30 373.35B 90.63B 22.66B 18.57B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
188.51 329.24B 57.37B 4.20B 15.39B 2.35
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
117.04 231.66B 55.19B 13.65B 16.81B 6.86
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
69.53 298.68B 43.59B 15.04B 10.74B 3.3766

Grifols Sa Adr Stock (GRFS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-12 Ripresa Morgan Stanley Overweight
2024-03-12 Downgrade Deutsche Bank Hold → Sell
2023-04-12 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2023-03-03 Downgrade Morgan Stanley Overweight → Equal-Weight
2023-02-16 Aggiornamento Barclays Underweight → Equal Weight
2023-01-18 Aggiornamento Jefferies Hold → Buy
2022-04-08 Iniziato Morgan Stanley Equal-Weight
2021-11-05 Downgrade Deutsche Bank Buy → Hold
2021-10-19 Downgrade Barclays Overweight → Underweight
2021-10-06 Aggiornamento Citigroup Neutral → Buy
2021-06-14 Aggiornamento Deutsche Bank Hold → Buy
2021-04-20 Iniziato Deutsche Bank Hold
2021-03-23 Aggiornamento Credit Suisse Neutral → Outperform
2021-03-11 Aggiornamento HSBC Securities Hold → Buy
2020-10-01 Aggiornamento Citigroup Sell → Neutral
2020-06-09 Downgrade Citigroup Neutral → Sell
2020-06-09 Aggiornamento HSBC Securities Reduce → Hold
2020-03-25 Downgrade Citigroup Buy → Neutral
2019-06-27 Aggiornamento JP Morgan Neutral → Overweight
2019-02-08 Downgrade Berenberg Buy → Hold
2018-10-11 Aggiornamento Berenberg Hold → Buy
2018-06-01 Iniziato Barclays Overweight
2017-10-31 Iniziato Citigroup Buy
2017-06-30 Downgrade Goldman Buy → Neutral
2017-04-06 Iniziato BofA/Merrill Buy
2017-01-03 Aggiornamento JP Morgan Neutral → Overweight
2016-02-09 Aggiornamento Berenberg Hold → Buy
2016-01-04 Downgrade Morgan Stanley Equal-Weight → Underweight
2015-12-02 Downgrade HSBC Securities Buy → Hold
2015-11-20 Downgrade Berenberg Buy → Hold
2015-04-28 Downgrade Berenberg Buy → Hold
Mostra tutto

Grifols Sa Adr Borsa (GRFS) Ultime notizie

pulisher
Jun 30, 2025

Oppenheimer Asset Management Inc. Acquires 23,980 Shares of Grifols, S.A. (NASDAQ:GRFS) - Defense World

Jun 30, 2025
pulisher
May 28, 2025

ADMA Biologics Vs. Grifols: Which Plasma Therapy Stock Is The Better Buy? - Barchart.com

May 28, 2025
pulisher
May 22, 2025

Grifols: If This Works Out, It Has Massive Upside (NASDAQ:GRFS) - Seeking Alpha

May 22, 2025
pulisher
May 02, 2025

Grifols S.A. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire

May 02, 2025
pulisher
Apr 28, 2025

SMRT’s latest rating updates from top analysts. - knoxdaily.com

Apr 28, 2025
pulisher
Apr 28, 2025

Investing in Grifols SA ADR (GRFS): What You Must Know - knoxdaily.com

Apr 28, 2025
pulisher
Apr 28, 2025

Investing in Apellis Pharmaceuticals Inc (APLS) Is Getting More Attractive - knoxdaily.com

Apr 28, 2025
pulisher
Apr 28, 2025

A company insider recently sold 10,000 shares of News Corp [NWSA]. Should You also Consider to Sale? - knoxdaily.com

Apr 28, 2025
pulisher
Apr 28, 2025

Raymond James Downgrades Truist Financial Corporation (TFC) to a Mkt perform from an Outperform - knoxdaily.com

Apr 28, 2025
pulisher
Apr 28, 2025

AT&T, Inc (T) rating upgrades by Exane BNP Paribas - knoxdaily.com

Apr 28, 2025
pulisher
Apr 25, 2025

Grifols SA ADR (GRFS) Stock: Uncovering a 52-Week Range and Trading Volume - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

Lazard Inc (LAZ) Stock: 52-Week Performance Insights and Trading Volume - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

Can Verra Mobility Corp Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

RYAN’s Market Whiplash: 0.32% YTD Rise, -10.03% Plunge in 30 Days - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

A significant driver of top-line growth: Grifols SA ADR (GRFS) - Sete News

Apr 25, 2025
pulisher
Apr 25, 2025

SpringWorks Therapeutics Inc (SWTX) Stock: From Low to High in 52 Weeks - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

There is no doubt that Coeur Mining Inc (CDE) ticks all the boxes. - Sete News

Apr 25, 2025
pulisher
Apr 23, 2025

GRFS (Grifols SA ADR) may reap gains as insiders became active recently - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

BHP’s latest rating updates from top analysts. - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

FHN’s latest rating updates from top analysts. - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

Lake Street’s latest rating for ORGO stock - knoxdaily.com

Apr 23, 2025
pulisher
Mar 26, 2025

Fox Corporation [FOX] stock was sold by MURDOCH KEITH RUPERT at the price of US$3.08 million - knoxdaily.com

Mar 26, 2025
pulisher
Mar 20, 2025

6 undervalued stocks with low beta - Morningstar

Mar 20, 2025
pulisher
Mar 10, 2025

Deutsche Bank raises Grifols SA price target to EUR11.00 - Investing.com India

Mar 10, 2025
pulisher
Feb 27, 2025

Grifols: Looking At The Longer-Term 2025-2027 Upside After No Sale (GRFS) - Seeking Alpha

Feb 27, 2025
pulisher
Feb 06, 2025

Get in on Grifols SA ADR’s (GRFS) buy-in window today! - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Wall Street analysts’ outlook for Douglas Elliman Inc (DOUG) - SETE News

Feb 06, 2025
pulisher
Feb 04, 2025

Financial Metrics Exploration: Understanding Accuray Inc (ARAY) Through Ratios - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Financial Fitness Check: Examining Mannkind Corp (MNKD)’s Key Ratios - The Dwinnex

Feb 04, 2025
pulisher
Feb 03, 2025

Orphan Designated Drugs Market Analysis: Key Trends, Players and Forecasts for Future Growth - GlobeNewswire Inc.

Feb 03, 2025
pulisher
Nov 29, 2024

Grifols: More Attractive Than In A Very Long Time (NASDAQ:GRFS) - Seeking Alpha

Nov 29, 2024
pulisher
Nov 28, 2024

Grifols Stock Declines After Brookfield Drops Buyout Offer - Yahoo Finance

Nov 28, 2024
pulisher
Nov 27, 2024

Brookfield Drops $6.8 Billion Offer to Buy Drugmaker Grifols - BNN Bloomberg

Nov 27, 2024
pulisher
Nov 20, 2024

Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8% - Yahoo Finance

Nov 20, 2024
pulisher
Nov 19, 2024

Grifols slips as board rebuffs Brookfield’s $6.8B offer (update) - MSN

Nov 19, 2024
pulisher
Nov 19, 2024

Grifols stock slips as Brookfield offer rebuffed (GRFS:NASDAQ) - Seeking Alpha

Nov 19, 2024
pulisher
Oct 03, 2024

Grifols: Here Is Why It's Still A 'Buy' Even If Price Goes Down (NASDAQ:GRFS) - Seeking Alpha

Oct 03, 2024
pulisher
Sep 08, 2024

UK Intravenous Immunoglobulin Market Size & Outlook, 2030 - Grand View Research

Sep 08, 2024
pulisher
Sep 03, 2024

The UAE Blood Transfusion Diagnostics Market Size & Outlook, 2027 - Grand View Research

Sep 03, 2024
pulisher
Aug 22, 2024

Why Grifols (GRFS) Stock Price Moved Up 7% on Wednesday - Yahoo Finance

Aug 22, 2024
pulisher
Aug 21, 2024

Grifols shares up on potential takeover by Brookfield - Investing.com

Aug 21, 2024
pulisher
Aug 10, 2024

China Intravenous Immunoglobulin Market Size & Outlook, 2030 - Grand View Research

Aug 10, 2024
pulisher
Aug 09, 2024

India Blood Transfusion Diagnostics Market Size & Outlook, 2027 - Grand View Research

Aug 09, 2024
pulisher
Jul 16, 2024

Grifols: Going Private? Brookfield On The Scene (OTCMKTS:GIFLF) - Seeking Alpha

Jul 16, 2024
pulisher
Apr 19, 2024

Grifols 2023 Annual Report on Form 20-F filed with the SEC - PR Newswire

Apr 19, 2024
pulisher
Mar 07, 2024

Grifols S.A. (GRFS – ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another Critical Report – Hagens Berman - ACCESS Newswire

Mar 07, 2024
pulisher
Feb 17, 2024

AMBAR, an Encouraging Alzheimer's Trial That Raises Questions - Frontiers

Feb 17, 2024
pulisher
Feb 16, 2024

The 10 Most-Bought and Most-Sold European Stocks - Morningstar

Feb 16, 2024
pulisher
Feb 05, 2024

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - Yahoo Finance

Feb 05, 2024
pulisher
Jan 25, 2024

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Grifols, S.A. - GlobeNewswire

Jan 25, 2024
pulisher
Jan 18, 2024

ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Grifols, - GlobeNewswire

Jan 18, 2024

Grifols Sa Adr Azioni (GRFS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
drug_manufacturers_general SNY
$49.69
price up icon 1.89%
$112.20
price up icon 1.95%
drug_manufacturers_general PFE
$25.35
price up icon 0.88%
$307.56
price up icon 0.42%
drug_manufacturers_general MRK
$82.97
price up icon 1.72%
drug_manufacturers_general NVO
$69.47
price up icon 3.96%
Capitalizzazione:     |  Volume (24 ore):